Efficacy and safety of Qingda granule versus valsartan capsule in Chinese grade 1 hypertensive patients with low-moderate risk: A randomized, double-blind, double dummy, non-inferiority, multi-center trial

Efficacy and safety of Qingda granule versus valsartan capsule in Chinese grade 1 hypertensive patients with low-moderate risk: A randomized, double-blind, double dummy, non-inferiority, multi-center trial

Background: The efficacy and safety of Qingda granule (QDG) in managing blood pressure (BP) among grade 1 hypertensive patients with low-moderate risk remain uncertain. Methods: In the randomized, double-blind, double dummy, non-inferiority and multicenter trial, 552 patients with grade 1 hypertensi...

Full description

Bibliographic Details
Main Authors: Hua Qu, A-ling Shen, Kuo Yang, Ming-yan Huang, Hong-zheng Li, Wen-wen Yang, Shu-yue Fan, Ling Tan, Jie Wang, Yu-xuan Peng, Jian-feng Chu, Jun Peng, Chang-geng Fu, Lin-zi Long, Ke-ji Chen
Format: Article
Language:English
Published: Elsevier 2024-02-01
Series:Pharmacological Research
Subjects:
Grade 1 hypertension
Qingda granule
Blood pressure
Adverse event
Online Access:http://www.sciencedirect.com/science/article/pii/S1043661823004085

Internet

http://www.sciencedirect.com/science/article/pii/S1043661823004085

Similar Items